Critical PDT Theory III: Events at the Molecular and Cellular Level
Author:
Open Access
- 31 May 2022
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (11) , 6195
Abstract
Photodynamic therapy (PDT) is capable of eradicating neoplastic cells that are accessible to sufficient light and oxygen. There is adequate information now available for assessing conditions where PDT might be the therapy of choice, but limited access to clinical facilities and impediments to regulatory approval of new agents have limited clinical usage. Early reports mainly involved clinical data with few thoughts towards finding death pathways. In 2022, there is a clear understanding of the determinants of successful tumor eradication. While PDT may be the optimal method for many clinical indications, support for this approach has lagged. This report provides a commentary on some elements of recent progress in PDT at the molecular and cellular levels, along with a discussion of some of the limitations in current research efforts.Keywords
This publication has 45 references indexed in Scilit:
- Lipoprotein-Inspired Nanoparticles for Cancer TheranosticsAccounts of Chemical Research, 2011
- On the use of fluorescence probes for detecting reactive oxygen and nitrogen species associated with photodynamic therapyJournal of Biomedical Optics, 2010
- Calpain-mediated cleavage of Atg5 switches autophagy to apoptosisNature Cell Biology, 2006
- Development of Novel Fluorescence Probes That Can Reliably Detect Reactive Oxygen Species and Distinguish Specific SpeciesJournal of Biological Chemistry, 2003
- Light Dosimetry for Intraperitoneal Photodynamic Therapy in a Murine Xenograft Model of Human Epithelial Ovarian CarcinomaPhotochemistry and Photobiology, 1998
- Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome cCell, 1996
- Benzophenothiazine and Benzoporphyrin Derivative Combination Phototherapy Effectively Eradicates Large Murine SarcomasPhotochemistry and Photobiology, 1996
- Photodynamic therapy with m‐tetrahydroxyphenylchlorin in vivo: Optimization of the therapeutic indexInternational Journal of Cancer, 1993
- Fast atom bombardment mass spectral analyses of Photofrin II® and its synthetic analogsJournal of Mass Spectrometry, 1990
- IN VIVO and POST MORTEM MEASUREMENTS OF THE ATTENUATION SPECTRA OF LIGHT IN MAMMALIAN TISSUESPhotochemistry and Photobiology, 1985